Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bio-Path Holdings Inc (BPTH)

Bio-Path Holdings Inc (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bio-Path: Q1 Earnings Snapshot AP - Wed May 20, 3:47PM CDT

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.0380 (-11.21%)
Bio-Path: Q3 Earnings Snapshot AP - Tue Jan 13, 11:02AM CST

Bio-Path: Q3 Earnings Snapshot

BPTH : 0.0380 (-11.21%)
Bio-Path: Q2 Earnings Snapshot AP - Thu Aug 14, 2025

Bio-Path: Q2 Earnings Snapshot

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum GlobeNewswire - Mon Jun 9, 2025

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings Provides Clinical and Operational Update GlobeNewswire - Tue Jun 3, 2025

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 GlobeNewswire - Thu May 22, 2025

BPTH : 0.0380 (-11.21%)
Bio-Path: Q1 Earnings Snapshot AP - Thu May 15, 2025

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients GlobeNewswire - Thu May 1, 2025

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings Reports Full Year 2024 Financial Results GlobeNewswire - Fri Mar 28, 2025

BPTH : 0.0380 (-11.21%)
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients GlobeNewswire - Tue Mar 18, 2025

BPTH : 0.0380 (-11.21%)

Barchart Exclusives

Dear Future SK Hynix Stock Investors, Mark Your Calendars for June 22 Barchart - Sun Jun 14, 1:00PM CDT
The SEC is anticipated to approve an application from SK Hynix to list in the U.S. the week of June 22. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.